Newsletter November 2022 – Accelerating Cline to the next phase
The year is speeding along and there are a lot of exciting updates about propelling both our projects and Cline forward in the future. This newsletter will give updates into our StemCART project and details about the upcoming Rights Issue, in which shareholders are able to subscribe until the 28th of November.In the lab with StemCART Much has been happening in the StemCART labs since we wrote about the project in the September newsletter. In that edition, we went through the exvivo project results gained this year and the three goals the team achieved. You can read more about these goals